| Breast Cancer |
1 |
1 |
| Sarcoma |
0 |
0.87 |
| Skin Cancer |
0 |
0.79 |
| Angiosarcoma |
0 |
0.99 |
| Breast |
0 |
0.5 |
| Tumor |
0 |
0.43 |
| Biologic Therapy |
0 |
0.42 |
| Genomic Medicine |
0 |
0.37 |
| Dermatitis |
0 |
0.29 |
| Cancer |
0 |
0.28 |
| Targeted Cancer Therapy |
0 |
0.27 |
| Paget Disease |
0 |
0.15 |
| Oncogene |
0 |
0.14 |
| Patient History |
0 |
0.14 |
| Adjuvant Chemotherapy |
0 |
0.1 |
| Tyrosine Kinase Inhibitor |
0 |
0.1 |
| Complementary and Alternative Medicine |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.09 |
| Actinic Skin Damage |
0 |
0.07 |
| Anthracyclines |
0 |
0.07 |
| Board Certification |
0 |
0.07 |
| Cervical Region |
0 |
0.07 |
| Chemotherapy |
0 |
0.07 |
| Concerns of Elderly |
0 |
0.07 |
| Eczema |
0 |
0.07 |
| Geriatrics |
0 |
0.07 |
| Histology |
0 |
0.07 |
| Internet |
0 |
0.07 |
| Lymphedema |
0 |
0.07 |
| Osteopathic Medicine |
0 |
0.07 |
| Perioperative Care |
0 |
0.07 |
| Private Practice |
0 |
0.07 |
| Prognosis |
0 |
0.07 |
| Radiation Therapy |
0 |
0.07 |
| Resection |
0 |
0.07 |
| Stewart-Treves Syndrome |
0 |
0.07 |
| Surgery |
0 |
0.07 |
| Taxane |
0 |
0.07 |
| Tyrosine Kinase |
0 |
0.07 |
| Vascular Endothelial Growth Factor |
0 |
0.07 |